Immunosuppressive Therapy
Immunosuppressive Therapy is a pharmacologic treatment strategy that uses agents to attenuate or modulate components of the immune response in a controlled manner to prevent or treat allograft rejection and other immune-mediated injury while balancing risks of infection, malignancy, and drug-related toxicity.
8K
Publications
443.1K
Citations
39.4K
Authors
5K
Institutions
Publications per year
2017–2026
1.2K
Variants
Immunosuppression TherapyImmunosuppressive Treatment
8K
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C. Huang, Wei Zhang et al. · Nature · 2018 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +14
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text
Medicine, Immunology, Pharmacology +17
1–5 of 8K
39.4K
34
h-index
32
h-index
31
h-index
26
h-index
25
h-index
1–5 of 39.4K
5K
Harvard University
Cambridge, United States
61 h-index
731 publications
59.6K citations
University of Pittsburgh
Pittsburgh, United States
56 h-index
732 publications
53.6K citations

Johns Hopkins University
Baltimore, United States
54 h-index
603 publications
49.2K citations
Inserm
Paris, France
54 h-index
601 publications
55.2K citations
Stanford University
Stanford, United States
51 h-index
452 publications
83.5K citations
National Institutes of Health
Bethesda, United States
49 h-index
389 publications
29.9K citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
43 h-index
370 publications
23K citations
Massachusetts General Hospital
Boston, United States
43 h-index
340 publications
30.2K citations
1–8 of 5K
943 publications · 57.4K citations
116
h-index
Repository · 1K publications · 36.3K citations
84
h-index
167 publications · 17.4K citations
80
h-index
198 publications · 16.9K citations
69
h-index
JI · 114 publications · 10.3K citations
55
h-index
1–5